SABCS 2025 – Dr. Frederick Howard on Digital Histology

Dr. Frederick Howard, breast oncologist at the University of Chicago, discusses SABCS 2025 data on how digital histology models can predict recurrence risk and chemotherapy benefit in early-stage HR+/HER2- breast cancer, complementing traditional gene-expression testing.